-+ 0.00%
-+ 0.00%
-+ 0.00%

Hoth Therapeutics Receives Patent Coverage From China National Intellectual Property Administration Covering HT-KIT Cancer Program

Benzinga·01/21/2026 13:18:12
Listen to the news

Hoth Therapeutics, Inc. (NASDAQ:HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced that the China National Intellectual Property Administration has approved issuance of a key patent covering the Company's HT-KIT cancer program, a novel therapeutic approach designed to induce apoptosis in disease-driving cells by targeting KIT signaling pathways.